Evelo Biosciences, Inc.

VANGUARD GROUP INC EVLO

Report date

3/31/2023

Quarter

2023 Q1

Filed

7/14/2023

Shares

3,168,375

Value ($000)

573

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	7/14/2023	573	0.0%	3,168,375	3/31/2023
2022 Q4	2/10/2023	5,101	0.0%	3,168,375	12/31/2022
2022 Q3	11/14/2022	6,735	0.0%	3,222,420	9/30/2022
2022 Q2	8/12/2022	2,870	0.0%	1,360,322	6/30/2022
2022 Q1	5/13/2022	5,235	0.0%	1,544,518	3/31/2022
2021 Q4	2/14/2022	8,571	0.0%	1,411,816	12/31/2021
2021 Q3	11/12/2021	10,532	0.0%	1,495,887	9/30/2021
2021 Q2	8/13/2021	20,291	0.0%	1,476,784	6/30/2021
2021 Q1	5/14/2021	14,479	0.0%	1,353,224	3/31/2021
2020 Q4	2/12/2021	13,952	0.0%	1,154,066	12/31/2020
2020 Q3	11/16/2020	4,674	0.0%	886,960	9/30/2020
2020 Q2	8/14/2020	4,277	0.0%	873,054	6/30/2020
2020 Q1	5/15/2020	1,602	0.0%	426,712	3/31/2020
2019 Q4	2/14/2020	1,729	0.0%	425,768	12/31/2019